PineTree Therapeutics in Cambridge, MA, seeks a Director of Developability and Early CMC Development to lead analytical method development, developability assessment, and cell line development for monoclonal and multispecific antibodies. You will oversee CRO/CDMO collaborations, guide candidate selection, and drive IND readiness in a fast-growing biotech environment.
The role requires senior scientific leadership, experience with analytical and purification technologies, and a track record of
#J-18808-Ljbffr